Now, scientists can "design" proteins with the precision of programming. This is no longer science fiction, but a reality being created by the Dutch company Cradle.

In the grand landscape of biotechnology, Cradle's founder, Steve van Griensven, likens proteins to an "alien programming language." His team is using artificial intelligence to decode this mysterious language, bringing revolutionary changes to biotechnology.

Traditional protein development has been like a long and costly blind exploration. Researchers must go through dozens of experimental rounds, each costing tens of thousands to hundreds of thousands of dollars. However, Cradle uses AI to compress this process to unprecedented efficiency.

image.png

For example, if scientists need a protein that is more stable at high temperatures, it used to require repeated experiments. Now, Cradle's AI model can directly identify and recommend the best sequences, maintaining the original function while enhancing the protein's heat resistance. It's like finding the optimal solution for the code of life.

Even more astonishing is that Cradle's business model is so simple and elegant: a plug-and-play software service. There are no complicated royalties, revenue sharing, or intellectual property disputes. Researchers can focus on innovation instead of getting bogged down in tedious business negotiations.

The recently secured $73 million in funding will be used to expand laboratories and recruit more top talent. Van Griensven's ultimate goal is to make this technology accessible to a million scientists, which is essentially a "moon landing" for the biotechnology field.

In the vast universe of life sciences, AI is quietly becoming the most powerful exploration tool. Cradle is redefining the possibilities of protein design with intelligence, proving that the boundaries of technology and imagination are continuously being pushed.

This is not just the story of a company; it is yet another stunning attempt by humanity to understand and reshape the essence of life.